From Science to Startup: Building a Venture at the Intersection of Women’s Health + Innovation with Dr. Rhonda Voskuhl of CleopatraRX
Women’s health is one of the fastest-growing frontiers of innovation—and yet it remains one of the most underfunded. What does it take to build a company that not only addresses a massive unmet need but also sparks a cultural shift?
Join us for an exclusive LinkedIn Live with Dr. Rhonda Voskuhl—neurologist, award-winning researcher, and founder of CleopatraRX—as she shares how she transformed decades of groundbreaking science into a startup tackling one of the most overlooked challenges in women’s lives: menopause brain fog.
For founders, Dr. Voskuhl’s journey offers a playbook for taking a bold idea from concept to company:
Fundraising with intention: why she started small with aligned institutional backers and how she’s structuring her next raise
Scaling with simplicity: her subscription-based DTC model that meets customers where they are and drives recurring revenue
Teaming up wisely: how she paired scientific expertise with seasoned commercial leadership to accelerate execution
Media as a growth engine: leveraging platforms like the Today Show and Oprah’s Menopause Revolution to build awareness and credibility
This conversation isn’t just about women’s health—it’s about the mindset and strategies it takes to pioneer in any industry where the market has overlooked women.
MEET OUR SPEAKER
Dr. Rhonda Voskuhl is a renowned neurologist, researcher, women's health advocate, menopause expert and Professor of Neurology at UCLA, where she directs the university’s Multiple Sclerosis Program. Widely recognized for her groundbreaking work on sex differences in male and female, she has led pivotal research showing how hormones like estrogen can protect the brain and influence cognitive decline. Building on this work, Dr. Voskuhl is also advancing women’s health through CleopatraRX, a company she founded that is pioneering hormone-based therapies to support women through the menopause "brain fog". Her career bridges cutting-edge science and compassionate patient care, making her a leading voice in both neurology and women’s health innovation.